Welcome to LookChem.com Sign In|Join Free
  • or
3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate is a complex organic compound characterized by its unique molecular structure. It is derived from a pyridine base and features a cinnamyl group, a methoxyethyl group, and a nitrophenyl group attached to its structure. 3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate exhibits a diverse range of chemical properties due to its intricate molecular composition, making it a potential candidate for various applications in different industries.

146845-34-3

Post Buying Request

146845-34-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

146845-34-3 Usage

Uses

Used in Pharmaceutical Industry:
3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate is used as a pharmaceutical compound for its potential therapeutic applications. The compound's unique structure allows it to interact with specific biological targets, making it a promising candidate for the development of new drugs. Its ability to modulate various signaling pathways and receptors can be harnessed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular conditions.
Used in Chemical Synthesis:
In the field of chemical synthesis, 3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate can be utilized as a key intermediate or building block for the synthesis of more complex molecules. Its versatile structure enables it to be further modified or functionalized to create novel compounds with specific properties and applications.
Used in Material Science:
3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate may also find applications in material science, particularly in the development of advanced materials with unique properties. Its molecular structure can be exploited to design materials with enhanced mechanical, electrical, or optical characteristics, which can be used in various applications such as sensors, energy storage devices, or advanced coatings.
Used in Cosmetics Industry:
The compound's unique structure and properties may also make it suitable for use in the cosmetics industry. It could potentially be used as an active ingredient in skincare products, hair care formulations, or makeup due to its ability to interact with biological targets and modulate various signaling pathways.

Check Digit Verification of cas no

The CAS Registry Mumber 146845-34-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,8,4 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 146845-34:
(8*1)+(7*4)+(6*6)+(5*8)+(4*4)+(3*5)+(2*3)+(1*4)=153
153 % 10 = 3
So 146845-34-3 is a valid CAS Registry Number.

146845-34-3Upstream product

146845-34-3Downstream Products

146845-34-3Relevant academic research and scientific papers

Isolation and characterization of novel degradation products in cilnidipine by LC-QTOF-MS/MS, LCMSn, 2D-NMR and FTIR

Krishnam Raju,Shanmukha Kumar,Goud Palusa, Sanath Kumar

, p. 634 - 646 (2018)

Cilnidipine (CIL) is a novel calcium antagonist accompanied with L-type and N-type calcium channel blocking functions. The drug was subjected to stress studies as per the international conference on harmonization guidelines (ICH) Q1A (R2) to understand the degradation profile of the drug. In the present study, seven degradation products were detected by simple mass compatible high performance liquid chromatography (HPLC) and tentatively characterized using high resolution mass spectrometry. Of these, three oxidative degradation (CD1, CD2 & CD3) products were isolated from the reaction mass using preparative HPLC and their structures were elucidated comprehensively using high resolution and multistage mass fragmentation studies, multidimensional nuclear magnetic resonance and in spectroscopic techniques. Formation of racemic mixtures for each CD1 and CD2 were verified by chiral HPLC. Stereo centers for CD1 and CD2 were fixed using ROESY data as 1S, 2S, 3S, 4R, 5R (and its enantiomer) and 1S, 2S, 3R, 4R, 5R (and its enantiomer). To the best of our knowledge, CD1 and CD2 were novel structures which have not been discussed in any form of publication as yet. The proposed structures of CD1, CD2 and CD3 have been rationalized by appropriate mechanisms.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 146845-34-3